Open original FDA record ↗Recall record
- FDA identifier
- Z-0839-2019
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- Feb 15, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Calcium assay on RX instruments. Carryover to the Calcium reagent results may result in falsely elevated or decreased results to both patient and QC samples.
Source facts
- Action
- Randox the US distributor contacted customers by email on 12/4/18 to advise of problem and provided an update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Calcium assay on RX instruments.The instrument testing order should be reviewed in line with the updated technical bulletin. A revised letter issued 12 Feb 2019 to advise "reagent would be observed as inconsistencies in Quality control recovery which may lead to a delay in running patient samples or erroneous elevated / depressed test results".
- Initiated
- 2018-12-04
- Root cause
- Device Design
- Terminated
- 2020-06-18
- Distribution
- WV, PR
- Recall number
- Z-0839-2019
- Recall status
- Terminated
- CDRH record ID
- 169689
- FDA record created
- 2019-02-15
- Recall event number
- 81746